Technical Data
N2567-05
NIK, Recombinant, Human (NF-kappa-beta-inducing Kinase, HsNIK, FTDCR1B, HS, Mitogen-activated Protein Kinase Kinase Kinase 14, MAP3K14, Serine/threonine Protein Kinase NIK)
10ug
|
Technical Data |
|
N2567-05 |
NIK, Recombinant, Human (NF-kappa-beta-inducing Kinase, HsNIK, FTDCR1B, HS, Mitogen-activated Protein Kinase Kinase Kinase 14, MAP3K14, Serine/threonine Protein Kinase NIK) |
10ug |
| Molecular Biology | Storage: -70°CShipping: Dry Ice |
|
Human MAP3K14 (mitogen-activated protein kinase kinase kinase 14; NIK; GenBank Accession No. NM_003954), (a.a. 318-end) with N-terminal GST tag. Applications: Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. Recommended Dilutions: Optimal dilutions to be determined by the researcher. Storage and Stability: Aliquot to avoid repeated freezing and thawing and store at -70°C. Aliquots are stable for 6 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Molecular Weight: ~96kD |
Source: Baculovirus infected Sf9 cell expression system Purity: 65% Purified by glutathione affinity column, followed by a superdex 200 gel filtration coulumn. Concentration: ~0.1mg/ml Form: Supplied as a liquid in 40mM Tris-HCl, pH 8.0, 110mM sodium chloride, 2.2mM potassium chloride, 3mM DTT, 10% glycerol. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
1. Nadiminty,N. et al., Biochem. Biophys. Res. Commun. 359 (2), 379-384 (2007). 2. Bode,L., Murch,S. and Freeze,H.H., J. Biol. Chem. 281 (12), 7809-7815 (2006).
|
||